Definium Therapeutics is a late-stage clinical biopharmaceutical company focused on developing accessible treatments for psychiatric and neurological disorders by applying scientific rigor to psychedelics. Our mission is to forge a new era of psychiatry. Our lead product candidate is lysergide tartrate, a proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate, aimed at treating generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our pipeline also includes DT402, the R-enantiomer of MDMA, for the core symptoms of autism spectrum disorder. We are headquartered in New York and trade on Nasdaq under the symbol DFTX. The Medical Science Liaison (MSL) will be a field-based scientific and clinical expert supporting our psychiatry portfolio. This role involves building and maintaining relationships with Key Opinion Leaders (KOLs), healthcare providers, policy influencers, and other stakeholders. The MSL will engage the medical community to communicate scientific data, gather clinical insights, and ensure alignment between research and development efforts and real-world practice needs. The ideal candidate will possess a strong foundation in psychiatric disorders, a passion for science-driven conversations, and the ability to thrive in a fast-growing biotech environment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level